Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
MEDIUM RISK
Score updated Oct 13, 2026

BBNX — Beta Bionics, Inc. Dilution Risk Tracker

Track BBNX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BBNX — Get alerts when the score changes →

As of October 13, 2026, Beta Bionics, Inc. (BBNX) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. Beta Bionics, Inc. has a market capitalization of $803.52M, 44.99M shares outstanding, 132 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
50
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BBNX.
🔔 Track BBNX — Get forecast alerts →

Market Data

Market Cap$803.52M
Shares Outstanding44.99M
Float25.37M
Cash$180.49M
Debt$6.91M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore32/100DilutionWatch score record
Shares Outstanding44.99MVerified float table or market cache
Public Float25.37MVerified float table or market cache
Market Cap$803.52MMarket data cache
Cash Runway28.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.6% shares (2026Q1 vs prior)
132 institutional holders · 59.89M shares
#1 MORGAN STANLEY 11.45M shares
#2 EVENTIDE ASSET MANAGEMENT, LLC 5.95M shares
#3 Soleus Capital Management, L.P. 4.35M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.05M
Days to Cover3.2
% of Float23.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-07-29
xbrl XBRL CONVERTIBLE 2026-02-24
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-03-05
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BBNX Dilution Snapshot

Beta Bionics, Inc. (BBNX) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BBNX's DilutionScore is currently 32/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 30/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202632/100MEDIUM1 day
Jul 16 – Oct 12, 202630/100MEDIUM88 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BBNX shares outstanding have increased 0.4% from 44.38M (Mar 2026) to 44.56M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202644.56M25.37M▼ 5.14%
May 15, 202644.56M26.75M▲ 23.17%
May 11, 202644.56M21.72M▼ 8.27%
Apr 23, 202644.56M23.68M▲ 0.40%
Apr 13, 202644.38M23.58M▲ 0.36%
Mar 28, 202644.38M23.50M▼ 2.84%
Mar 09, 202644.38M24.18M▼ 0.45%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BBNX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BBNX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BBNX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BBNX
BBNX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.